Stay updated on Etrasimod in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.

Latest updates to the Etrasimod in Ulcerative Colitis Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the phase 2 etrasimod study in ulcerative colitis is available with its study details, results measures, participant criteria, locations, publications, and supporting documents.SummaryDifference98%

- Check12 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH banner announces a terminology transition under Executive Order 14434, and the site revision changes from v3.7.1 to v3.7.2. The study record still displays a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange Detected- The page now displays a 403 Forbidden error page, replacing the previous study record content with a minimal header and a Home link.SummaryDifference16%

- Check61 days agoChange DetectedA new Revision: v3.7.0 tag appears on the page, replacing the previous Revision: v3.6.6 tag. This signals an updated version of the study record documentation.SummaryDifference0.0%

Stay in the know with updates to Etrasimod in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.